Comparable companies
- Dr. Camille VerellenAntwerpen
- Huisarts De SmulBrasschaat
- PLAN HuisartsenAalst
- DOKTER LEEN PACOLETTienen
- Centrum Medische ExpertiseSchilde
Alexandra GILISSEN
ActiveFrom the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Summary
Alexandra GILISSEN has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €12,256 and a net result of €8,256. Its solvency ranks better than 40% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
Official details
KBO- Status
- Active since 15-09-2025 Normal situation
- Legal form
- Private limited company
- Registered office
- Veydtstraat 56, 1050 Elsene
- Activity
- General medical practice NACE 86210
- Establishment unit
- 2.378.564.615 1050 Elsene, since 15-09-2025
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
How it is doing
- Bankruptcy probabilitywithin 12 months
- < 0.1%
Annual accounts 2025
- Gross margin
- €11,016
- Turnover
- ≈ €72,000
- estimated
- Profit
- €8,256
- Equity
- €12,256
- Total assets
- €24,178
2025 accounts 28 days early
Filed on 03-07-2026at the National Bank
Why 95lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.95, cash €22,319Figures for financial year 2025 (filed 03-07-2026)Equity €12,256 (50.7% of total assets)Show the evidence
Checked score
Score 2025
95
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 59% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency
76
equity 50.7% of total assets
Liquidity
75
short-term debt 49.3% · cash 92.3%
Profitability
100
return on assets 34.1%
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.95, above the usual 1.5; short-term debt: 49.3% and cash: 92.3% of total assets), and 49.3% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 40% on solvency, 57% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
28 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
Key points
- Caution: Among the weakest 14% on equitysector median €124,506 · 20,661 companies €12,256 View
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 03-07-2026
Acts in the Belgian Official Gazette
- Incorporationact of 17-09-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Alexandra GILISSEN
- What is the company number of Alexandra GILISSEN?
- 1027.652.345. In Belgium the VAT number is the company number with BE in front: BE 1027.652.345.
- Where is Alexandra GILISSEN based?
- The registered office is at Veydtstraat 56, 1050 Elsene.Company details
- What does Alexandra GILISSEN do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of Alexandra GILISSEN?
- Private limited company (BV).
- When was Alexandra GILISSEN founded?
- On 15-09-2025.
- Is Alexandra GILISSEN still active?
- Yes, Alexandra GILISSEN is an active enterprise in the KBO register.
- What is the turnover of Alexandra GILISSEN?
- ≈ €72,000 in financial year 2025. Estimated from the gross margin of €11,016: probably between €50,000 and €120,000, based on 48 comparable companies, NACE 86. A rough estimate.Financials
- Is Alexandra GILISSEN profitable?
- In financial year 2025, Alexandra GILISSEN made a profit of €8,256.
- Where can I find the annual accounts of Alexandra GILISSEN?
- Alexandra GILISSEN filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank
Companies related to Alexandra GILISSEN
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.